Medicure (MCUJF) Current Deferred Revenue (2016 - 2022)

Medicure's Current Deferred Revenue history runs 7 years deep, the most recent figure standing at $131869.8 for Q4 2022.

• In Q4 2022, Current Deferred Revenue fell 60.7% year-over-year to $131869.8; the TTM figure through Dec 2022 stood at $131869.8 (down 60.7% YoY), while the FY2022 annual figure was $131869.8, down 60.7% from the prior year.
• Current Deferred Revenue was $131869.8 for Q4 2022 at Medicure, down from $335581.2 in the prior quarter.
• In the past five years, Current Deferred Revenue ranged from a high of $1.1 million in Q4 2018 to a low of $131869.8 in Q4 2022.
• Historically, Current Deferred Revenue has averaged $491189.0 across 5 years, with a median of $371826.3 in 2021.
• The sharpest annual moves came in 2018 and 2022: Current Deferred Revenue jumped 4904.56% in 2018, then slumped 60.7% in 2022.
• A 5-year view of Current Deferred Revenue shows it stood at $1.1 million in 2018, then sank by 41.72% to $660538.6 in 2019, then plunged by 57.96% to $277673.8 in 2020, then rose by 20.85% to $335581.2 in 2021, then plunged by 60.7% to $131869.8 in 2022.
• The last three Current Deferred Revenue figures came in at $131869.8 (Q4 2022), $335581.2 (Q4 2021), and $277673.8 (Q4 2020), per Business Quant data.